CanaQuest Medical Corp. (CANQF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -273.23 Thousand | -488 Thousand | -190.85 Thousand | -69.51 Thousand | -34.36 Thousand | 27.53 Thousand |
| Net Income | -1.38 Million | -832.82 Thousand | -597.13 Thousand | -202.16 Thousand | -896.17 Thousand | -1.1 Million |
| Depreciation & Amortization | 20.36 Thousand | 5382.00 | 5258.10 | 4212.42 | 4400.43 | 15.7 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 929.94 Thousand |
| Change in working capital | 264.8 Thousand | -69.15 Thousand | -9028.82 | 34.24 Thousand | 19.4 Thousand | -64.64 Thousand |
| Other non-cash items | 886.47 Thousand | 422 Thousand | 420.62 Thousand | 71.23 Thousand | 857.89 Thousand | 247.61 Thousand |
| Investing Cash Flow | - | -2999.00 | -12.89 Thousand | -1437.17 | - | - |
| Investments in PPE | 1.00 | -2999.00 | -12.89 Thousand | -1437.17 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 269.21 Thousand | 474.41 Thousand | 218.72 Thousand | 71.92 Thousand | 31.69 Thousand | -27.61 Thousand |
| Debt repayment | -259.53 Thousand | -203.36 Thousand | -143.18 Thousand | -75.97 Thousand | - | -134.25 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -21.68 Thousand | - | - | - |
| Common Stock Issuance | 458.88 Thousand | 221.95 Thousand | 111.65 Thousand | - | - | - |
| Other Financing Activities | 69.86 Thousand | 49.09 Thousand | -14.42 Thousand | -4046.01 | 31.69 Thousand | 106.63 Thousand |
| Accounts receivables | -18.3 Thousand | -2646.00 | -56.62 | 31.38 Thousand | -11.08 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 283.11 Thousand | -66.51 Thousand | -8972.19 | 2863.75 | 30.49 Thousand | - |
| Cash at beginning of period | 4098.00 | 16.55 Thousand | 1506.94 | 421.54 | 3107.15 | 87.00 |
| Cash at end of period | 78.00 | 4098.00 | 16.55 Thousand | 1506.94 | 421.54 | 8.00 |
| Capital Expenditure | 1.00 | -2999.00 | -12.89 Thousand | -1437.17 | - | - |
| Effect of forex changes on cash | - | 4124.00 | 66.00 | 106.57 | - | - |
| Net cash flow / Change in cash | -4020.00 | -12.46 Thousand | 15.05 Thousand | 1085.40 | -2685.61 | -79.00 |
| Free Cash Flow | -273.23 Thousand | -491 Thousand | -203.74 Thousand | -70.94 Thousand | -34.36 Thousand | 27.53 Thousand |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -338.12 Thousand | -700.65 Thousand | -1.38 Million | -497.32 Thousand | -79.23 Thousand | -108.61 Thousand |
| Depreciation & Amortization | 186.00 | 16.67 Thousand | 20.36 Thousand | 1231.00 | 1231.00 | 1231.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 94.14 Thousand | 281.17 Thousand | 264.8 Thousand | 70.31 Thousand | -50.06 Thousand | -36.59 Thousand |
| Other non-cash items | 226.68 Thousand | 414.31 Thousand | 886.47 Thousand | 405.79 Thousand | 15.5 Thousand | 50.81 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 17.51 Thousand | 41.76 Thousand | 269.21 Thousand | -14.37 Thousand | 150.79 Thousand | 91.05 Thousand |
| Debt repayment | -51.3 Thousand | -77.33 Thousand | -259.53 Thousand | -1631.17 | -108.73 Thousand | -75.11 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 62.44 Thousand | 94.79 Thousand | 458.88 Thousand | 141.68 Thousand | 131.58 Thousand | 90.85 Thousand |
| Other Financing Activities | 6379.00 | 24.29 Thousand | 69.86 Thousand | -157.69 Thousand | 127.94 Thousand | 75.32 Thousand |
| Accounts receivables | -54.00 | -21.26 Thousand | -18.3 Thousand | 23.21 Thousand | -20.71 Thousand | 450.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 94.19 Thousand | 302.43 Thousand | 283.11 Thousand | 47.09 Thousand | -29.34 Thousand | -37.04 Thousand |
| Cash at beginning of period | 78.00 | 1401.00 | 4098.00 | 15.02 Thousand | -28.00 | 4098.00 |
| Cash at end of period | 60.00 | 78.00 | 78.00 | 1401.00 | 15.02 Thousand | -22.00 |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -18.00 | -1323.00 | -4020.00 | -13.62 Thousand | 15.05 Thousand | -4120.00 |
| Free Cash Flow | -17.53 Thousand | -43.1 Thousand | -273.23 Thousand | 769.32 | -135.74 Thousand | -95.17 Thousand |
LRDC
603959
CEE
013520
IDTA
601169